Approvals/TGA/PRAMIPEX XR pramipexole dihydrochloride monohydrate 3.75 mg modified release tablet blister pack

Approved

STANDARD

PRAMIPEX XR pramipexole dihydrochloride monohydrate 3.75 mg modified release tablet blister pack

Arrotex Pharmaceuticals Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 0f4a45cda17cb478
Product Name: PRAMIPEX XR pramipexole dihydrochloride monohydrate 3.75 mg modified release tablet blister pack
Artg Id: 225583
Artg Name: PRAMIPEX XR pramipexole dihydrochloride monohydrate 3.75 mg modified release tablet blister pack
Sponsor: Arrotex Pharmaceuticals Pty Ltd
Company Detail Path: /organization/arrotex-pharmaceuticals-pty-ltd
Artg Date: 2015-06-17
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

0f4a45cda17cb478

Type

Standard